Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

29401
1
BIO-PATH HOLDINGS INC Bio-Path Holdings Reports Improved Financial Performance, Net Loss Reduction, and Capital Raises

Via official filing (AI summary) | over 1 year ago | 0 comments

29402
1
MANGOCEUTICALS, INC. Mangoceuticals Reports 45.6% Revenue Decline in Q3, Net Loss Increases Amid Migration Issues and Patent Acquisition

Via official filing (AI summary) | over 1 year ago | 0 comments

29403
1
Forza X1, Inc. Forza X1 Reports Significant Financial Decline, Net Loss, and Merger Agreement with Parent Company

Via official filing (AI summary) | over 1 year ago | 0 comments

29404
1
Twin Vee PowerCats, Co. Twin Vee PowerCats Reports Significant Revenue Decline and Increased Losses in Q3 and Nine Months 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29405
1
Allarity Therapeutics, Inc. Allarity Therapeutics Reports Improved Cash Position, Increased Operating Expenses, and Regulatory Challenges

Via official filing (AI summary) | over 1 year ago | 0 comments

29406
1
Thunder Bridge Capital Partners IV, Inc. Thunder Bridge Capital Partners IV Reports Financial Developments, Business Combination Deadline Extension

Via official filing (AI summary) | over 1 year ago | 0 comments

29407
1
Panbela Therapeutics, Inc. Panbela Therapeutics Reports Mixed Financial Results, Seeks Additional Capital

Via official filing (AI summary) | over 1 year ago | 0 comments

29408
1
VPR Brands, LP. VPR Brands Reports Decline in Revenues and Net Income in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

29409
1
TurnOnGreen, Inc. TurnOnGreen Reports 11% Revenue Growth, Significant Improvement in Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29410
1
Fortune Rise Acquisition Corp Fortune Rise Acquisition Corporation Reports Significant Financial Changes, Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

29411
1
DatChat, Inc. DatChat, Inc. Reports 21.5% Decline in Net Revenues, Improved Operational Efficiency in Nine Months Ended September 30, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29412
1
Jaws Mustang Acquisition Corp JAWS Mustang Acquisition Corporation Reports Mixed Financial Results, Announces Potential Business Combination

Via official filing (AI summary) | over 1 year ago | 0 comments

29413
1
Alset Inc. Alset Inc. Reports 401% Quarterly Revenue Growth, Narrowing Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

29414
1
SPAR Group, Inc. Spar Group Reports 43.8% Decrease in Q3 Net Revenues, Net Loss, and Operating Loss Amid Challenging Market Environment

Via official filing (AI summary) | over 1 year ago | 0 comments

29415
1
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Reports Nine-Month Financial Results, Highlights Decreased Expenses and Losses

Via official filing (AI summary) | over 1 year ago | 0 comments

29416
1
PRECISION OPTICS CORPORATION, INC. Precision Optics Corporation Reports Decline in Revenue and Increased Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29417
1
GlucoTrack, Inc. GlucoTrack Reports Significant Financial Challenges, Net Losses, and Doubt About Future Operations

Via official filing (AI summary) | over 1 year ago | 0 comments

29418
1
MILESTONE SCIENTIFIC INC. Milestone Scientific Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29419
1
Estrella Immunopharma, Inc. Estrella Immunopharma Reports Significant Financial Decline, Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

29420
1
AVENUE THERAPEUTICS, INC. Avenue Therapeutics Reports Net Loss and Increased Research Expenses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29421
1
Horizon Space Acquisition I Corp. Horizon Space Acquisition I Corp. Reports Net Income Decline, Liquidity Concerns in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments

29422
1
Envirotech Vehicles, Inc. Envirotech Vehicles Reports Significant Decline in Revenue and Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29423
1
Constellation Acquisition Corp I Constellation Acquisition Corp I Reports Improved Financial Performance, Reduced Losses, and Strategic Developments

Via official filing (AI summary) | over 1 year ago | 0 comments

29424
1
AYRO, Inc. Ayro Inc. Reports Significant Financial Changes in 10-Q Filing, Despite Revenue Decline

Via official filing (AI summary) | over 1 year ago | 0 comments

29425
1
GT Biopharma, Inc. GT Biopharma Reports Mixed Financial Results, Net Loss, and Ongoing Challenges in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments